Invention Grant
US09150550B2 Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
有权
取代的苯并咪唑和苯并吡唑作为CCR（4）拮抗剂
- Patent Title: Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
- Patent Title (中): 取代的苯并咪唑和苯并吡唑作为CCR（4）拮抗剂
-
Application No.: US14056702Application Date: 2013-10-17
-
Publication No.: US09150550B2Publication Date: 2015-10-06
- Inventor: Manmohan Reddy Leleti , Yandong Li , Venkat Reddy Mali , Jay Powers , Ju Yang
- Applicant: ChemoCentryx, Inc.
- Applicant Address: US CA Mountain View
- Assignee: ChemoCentryx, Inc.
- Current Assignee: ChemoCentryx, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Kilpatrick Townsend & Stockton LLP
- Agent William B. Kezer
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D401/14 ; C07D403/12 ; C07D401/04
Abstract:
Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
Public/Granted literature
- US20140121195A1 SUBSTITUTED BENZIMIDAZOLES AND BENZOPYRAZOLES AS CCR(4) ANTAGONISTS Public/Granted day:2014-05-01
Information query
